nih-gov/www.ncbi.nlm.nih.gov/books/n/mlprobe/ml075/index.html?report=reader
2025-03-17 02:05:34 +00:00

561 lines
166 KiB
Text

<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
<head>
<!-- For pinger, set start time and add meta elements. -->
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<!-- Logger begin -->
<meta name="ncbi_db" content="books">
<meta name="ncbi_pdid" content="book-part">
<meta name="ncbi_acc" content="NBK47354">
<meta name="ncbi_domain" content="mlprobe">
<meta name="ncbi_report" content="reader">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_objectid" content="">
<meta name="ncbi_pcid" content="/NBK47354/?report=reader">
<meta name="ncbi_pagename" content="Probe Report for NPY-Y2 Receptor Antagonists - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf">
<meta name="ncbi_bookparttype" content="chapter">
<meta name="ncbi_app" content="bookshelf">
<!-- Logger end -->
<!--component id="Page" label="meta"/-->
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Probe Report for NPY-Y2 Receptor Antagonists - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf</title>
<meta charset="utf-8">
<meta name="apple-mobile-web-app-capable" content="no">
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
<meta name="jr-col-layout" content="auto">
<meta name="jr-prev-unit" content="/books/n/mlprobe/ml076/?report=reader">
<meta name="jr-next-unit" content="/books/n/mlprobe/ml071/?report=reader">
<meta name="bk-toc-url" content="/books/n/mlprobe/?report=toc">
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
<meta name="citation_inbook_title" content="Probe Reports from the NIH Molecular Libraries Program [Internet]">
<meta name="citation_title" content="Probe Report for NPY-Y2 Receptor Antagonists">
<meta name="citation_publisher" content="National Center for Biotechnology Information (US)">
<meta name="citation_date" content="2010/08/06">
<meta name="citation_author" content="SA Saldanha">
<meta name="citation_author" content="SP Brothers">
<meta name="citation_author" content="T Spicer">
<meta name="citation_author" content="M Cameron">
<meta name="citation_author" content="BA Mercer">
<meta name="citation_author" content="P Chase">
<meta name="citation_author" content="P McDonald">
<meta name="citation_author" content="C Wahlestedt">
<meta name="citation_author" content="PS Hodder">
<meta name="citation_pmid" content="21433370">
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK47354/">
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
<meta name="DC.Title" content="Probe Report for NPY-Y2 Receptor Antagonists">
<meta name="DC.Type" content="Text">
<meta name="DC.Publisher" content="National Center for Biotechnology Information (US)">
<meta name="DC.Contributor" content="SA Saldanha">
<meta name="DC.Contributor" content="SP Brothers">
<meta name="DC.Contributor" content="T Spicer">
<meta name="DC.Contributor" content="M Cameron">
<meta name="DC.Contributor" content="BA Mercer">
<meta name="DC.Contributor" content="P Chase">
<meta name="DC.Contributor" content="P McDonald">
<meta name="DC.Contributor" content="C Wahlestedt">
<meta name="DC.Contributor" content="PS Hodder">
<meta name="DC.Date" content="2010/08/06">
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK47354/">
<meta name="description" content="Due to its expression profile and biological action, neuropeptide Y (NPY)-Y2 receptor (Y2R) is an attractive G protein-coupled receptor (GPCR) target for anxiolytic research. Additionally, NPY-Y2R is predicted to be a therapeutic target in alcoholism. Four different compounds, ML075 (CID-2936384), ML074 (CID-2228302), ML073 (CID-3236979) and ML072 (CID-4460128) are claimed as novel antagonist probes to the NPY-Y2R, producing increased cAMP (3',5'-cyclic-AMP phosphodiesterase) levels. These probes demonstrate submicromolar affinity to the Y2 receptor, do not antagonize NPY-Y1R, do not present significant cytotoxicity, and are blood-brain barrier penetrant. Hence, these probes represent an improvement over previously described NPY-Y2R antagonists and offer greater promise to serve as valuable in vivo pharmacological probes for elucidating the Y2R signaling pathway.">
<meta name="og:title" content="Probe Report for NPY-Y2 Receptor Antagonists">
<meta name="og:type" content="book">
<meta name="og:description" content="Due to its expression profile and biological action, neuropeptide Y (NPY)-Y2 receptor (Y2R) is an attractive G protein-coupled receptor (GPCR) target for anxiolytic research. Additionally, NPY-Y2R is predicted to be a therapeutic target in alcoholism. Four different compounds, ML075 (CID-2936384), ML074 (CID-2228302), ML073 (CID-3236979) and ML072 (CID-4460128) are claimed as novel antagonist probes to the NPY-Y2R, producing increased cAMP (3',5'-cyclic-AMP phosphodiesterase) levels. These probes demonstrate submicromolar affinity to the Y2 receptor, do not antagonize NPY-Y1R, do not present significant cytotoxicity, and are blood-brain barrier penetrant. Hence, these probes represent an improvement over previously described NPY-Y2R antagonists and offer greater promise to serve as valuable in vivo pharmacological probes for elucidating the Y2R signaling pathway.">
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK47354/">
<meta name="og:site_name" content="NCBI Bookshelf">
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-mlprobe-lrg.png">
<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@ncbibooks">
<meta name="bk-non-canon-loc" content="/books/n/mlprobe/ml075/?report=reader">
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK47354/">
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&amp;subset=latin" rel="stylesheet" type="text/css">
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
<meta name="format-detection" content="telephone=no">
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
<meta name="ncbi_phid" content="CE8B032B7D6605610000000000B600A6.m_5">
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
<body>
<!-- Book content! -->
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK47354/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
<style type="text/css">.st0{fill:#939598;}</style>
<g>
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
</g>
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/mlprobe/ml076/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Probe Report for NPY-Y2 Receptor Antagonists</div><div class="j">Probe Reports from the NIH Molecular Libraries Program [Internet]</div></div><div class="tail"><a href="/books/n/mlprobe/ml071/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK47354/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK47354/&amp;text=Probe%20Report%20for%20NPY-Y2%20Receptor%20Antagonists"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/mlprobe/?report=reader">Title Information</a><a href="/books/n/mlprobe/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK47354/?report=classic">Switch to classic view</a><a href="/books/NBK47354/pdf/Bookshelf_NBK47354.pdf">PDF (400K)</a><a href="/books/NBK47354/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK47354%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8B032B7D6605610000000000B600A6.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">&#10008;</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">&#10008;</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">&#9664;</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">&#9654;</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK47354_"><span class="title" itemprop="name">Probe Report for NPY-Y2 Receptor Antagonists</span></h1><p class="contribs">Saldanha SA, Brothers SP, Spicer T, et al.</p><p class="fm-aai"><a href="#_NBK47354_pubdet_">Publication Details</a></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="_abs_rndgid_" itemprop="description"><p>Due to its expression profile and biological action, neuropeptide Y (NPY)-Y2 receptor (Y2R) is an attractive G protein-coupled receptor (GPCR) target for anxiolytic research. Additionally, NPY-Y2R is predicted to be a therapeutic target in alcoholism. Four different compounds, ML075 (CID-2936384), ML074 (CID-2228302), ML073 (CID-3236979) and ML072 (CID-4460128) are claimed as novel antagonist probes to the NPY-Y2R, producing increased cAMP (3',5'-cyclic-AMP phosphodiesterase) levels. These probes demonstrate submicromolar affinity to the Y2 receptor, do not antagonize NPY-Y1R, do not present significant cytotoxicity, and are blood-brain barrier penetrant. Hence, these probes represent an improvement over previously described NPY-Y2R antagonists and offer greater promise to serve as valuable in vivo pharmacological probes for elucidating the Y2R signaling pathway.</p></div><div class="h2"></div><p><b>Assigned Assay Grant #:</b> 1 R21 NS056950-01</p><p><b>Screening Center Name &#x00026; PI:</b> Scripps Research Institute Molecular
Screening Center (SRIMSC); Hugh Rosen</p><p><b>Chemistry Center Name &#x00026; PI:</b> SRIMSC; Hugh Rosen</p><p><b>Assay Submitter &#x00026; Institution:</b> Claes Wahlestedt, The Scripps
Research Institute (TSRI)</p><p><b>PubChem Summary Bioassay Identifier (AID):</b>
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1791" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1791</a></p><div id="ml075.s1"><h2 id="_ml075_s1_">Probe Structure &#x00026; Characteristics</h2><p>Four different compounds are claimed as novel antagonist probes to the NPY-Y2
receptor. These four probes demonstrate sub-micromolar affinity to the Y2 receptor,
do not antagonize the Y1R receptor, and do not present significant cytotoxicity.
Additionally, they are all blood-brain barrier penetrant. In this regard they all
represent an improvement over the current NPY Y2 antagonist probe, BIIE 0246. The
four probes are illustrated below:</p><div id="ml075.fu1" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu1.jpg" alt="Scaffold 1 (Piperidine carbothioamide) [ML075]." /></div><h3><span class="title">Scaffold 1 (Piperidine carbothioamide) [ML075]</span></h3></div><div id="ml075.fu2" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu2.jpg" alt="Scaffold 2 (Arysulfamoyl benzamide) [ML074]." /></div><h3><span class="title">Scaffold 2 (Arysulfamoyl benzamide) [ML074]</span></h3></div><div id="ml075.fu3" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu3.jpg" alt="Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]." /></div><h3><span class="title">Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]</span></h3></div><div id="ml075.fu4" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu4.jpg" alt="Scaffold 4 (Dimethylisoxazole) [ML072]." /></div><h3><span class="title">Scaffold 4 (Dimethylisoxazole) [ML072]</span></h3></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075tu1"><a href="/books/NBK47354/table/ml075.tu1/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml075tu1" rid-ob="figobml075tu1"><img class="small-thumb" src="/books/NBK47354/table/ml075.tu1/?report=thumb" src-large="/books/NBK47354/table/ml075.tu1/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="ml075.tu1"><a href="/books/NBK47354/table/ml075.tu1/?report=objectonly" target="object" rid-ob="figobml075tu1">Table</a></h4></div></div></div><div id="ml075.s2"><h2 id="_ml075_s2_">Recommendations for the scientific use of this probe</h2><p>These probes are useful for assays aiming to block cellular NPY Y2 receptor (Y2R)
signaling, leading to increased cAMP levels, without inhibiting NPY Y1 receptor
(Y1R) activity. The representative (&#x0201c;best-in-class&#x0201d;)
compounds from scaffold 1 (<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17507305</a></b>), scaffold 2
(<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17413392</a></b>), scaffold 3 (<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-4242079</a></b>), and scaffold
4 (<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-22413249</a></b>) displace agonist from the Y2R with high affinity. These
probes bind to fewer off-target receptors than BIIE 0246, currently the most widely
used Y2R antagonist. Most importantly, and in contrast to BIIE 0246, these
best-in-class probes are brain penetrant and thus able to reach Y2R binding sites in
both the periphery and brain. Additional information regarding the compounds and
assays employed in this probe development campaign can be found in (<a class="bibr" href="#ml075.r1" rid="ml075.r1">1</a>).</p></div><div id="ml075.s3"><h2 id="_ml075_s3_">1. Scientific Rationale for Project</h2><p>Due to its expression profile and biological action, NPY Y2 is an attractive GPCR
target for anxiolytic research. Additionally, Y2 is predicted to be a therapeutic
target in alcoholism. It has been reported, however, that the complex structure and
high molecular weight of BIIE 0246 (the current NPY Y2 antagonist) limit its
usefulness as an <i>in vivo</i> pharmacological tool (<a class="bibr" href="#ml075.r2" rid="ml075.r2">2</a>). It is therefore necessary to produce brain penetrant,
high affinity selective ligands for the Y2 receptor.</p></div><div id="ml075.s4"><h2 id="_ml075_s4_">2. Project Description</h2><div id="ml075.s2b"><h3>a. Information for each Assay Implemented and Screening Run</h3><div id="ml075.s2bi"><h4>i. PubChem Bioassay Name(s), AID(s), Assay-Type (Primary, DR, Counterscreen,
Secondary)</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t1"><a href="/books/NBK47354/table/ml075.t1/?report=objectonly" target="object" title="Table 2" class="img_link icnblk_img figpopup" rid-figpopup="figml075t1" rid-ob="figobml075t1"><img class="small-thumb" src="/books/NBK47354/table/ml075.t1/?report=thumb" src-large="/books/NBK47354/table/ml075.t1/?report=previmg" alt="Table 2. PubChem BioAssay." /></a><div class="icnblk_cntnt"><h4 id="ml075.t1"><a href="/books/NBK47354/table/ml075.t1/?report=objectonly" target="object" rid-ob="figobml075t1">Table 2</a></h4><p class="float-caption no_bottom_margin">PubChem BioAssay. </p></div></div></div><div id="ml075.s6"><h4>ii. Assay Rationale &#x00026; Description</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t2"><a href="/books/NBK47354/table/ml075.t2/?report=objectonly" target="object" title="Table 3" class="img_link icnblk_img figpopup" rid-figpopup="figml075t2" rid-ob="figobml075t2"><img class="small-thumb" src="/books/NBK47354/table/ml075.t2/?report=thumb" src-large="/books/NBK47354/table/ml075.t2/?report=previmg" alt="Table 3. Assay Rationale and Description." /></a><div class="icnblk_cntnt"><h4 id="ml075.t2"><a href="/books/NBK47354/table/ml075.t2/?report=objectonly" target="object" rid-ob="figobml075t2">Table 3</a></h4><p class="float-caption no_bottom_margin">Assay Rationale and Description. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t3"><a href="/books/NBK47354/table/ml075.t3/?report=objectonly" target="object" title="Table 4" class="img_link icnblk_img figpopup" rid-figpopup="figml075t3" rid-ob="figobml075t3"><img class="small-thumb" src="/books/NBK47354/table/ml075.t3/?report=thumb" src-large="/books/NBK47354/table/ml075.t3/?report=previmg" alt="Table 4. Reagents and Source." /></a><div class="icnblk_cntnt"><h4 id="ml075.t3"><a href="/books/NBK47354/table/ml075.t3/?report=objectonly" target="object" rid-ob="figobml075t3">Table 4</a></h4><p class="float-caption no_bottom_margin">Reagents and Source. </p></div></div></div><div id="ml075.s7"><h4>iii. Summary of Results</h4><p>Compared to previously described Y2R antagonists, the compounds described
herein offer greater promise for elucidating the Y2R signaling pathway.</p></div></div><div id="ml075.s8"><h3>b. Probe Optimization</h3></div><div id="ml075.s9"><h3>i. Description of SAR &#x00026; chemistry strategy (including structure and
data) that led to the probe.</h3><p>Since receptor subtype selective antagonists were desired, compounds worth
follow-up from the Primary, Confirmation and Counterscreening were required to
exhibit an IC<sub>50</sub> value of less than 10 &#x003bc;M at Y2R and
greater than 35 &#x003bc;M at Y1 in dose response assays. Structures and
data for each probe can be found in the SAR tables. The chemistry strategy that
lead to each scaffold is described below:</p><p><b>Scaffold 1:</b> Based on the above criteria, one compound belonging
to the piperidine-carbothioamide scaffold was identified:
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17507305</a></b>. This compound does not share structural
similarities with the known NPY-Y2 antagonist BIIE 0246 or JNJ-5207787.
Analogs were purchased in powder form or reordered from the MLSMR in liquid
form and tested in dose response assays against both receptors. Results for
these analogs are summarized in the SAR table below.</p><p><b>Scaffold 2:</b> Based on the above criteria, a compound belonging to
the arysulfamoyl benzamide scaffold was identified:
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17413392</a></b>. This compound does not share structural
similarities with the known NPY-Y2 antagonist BIIE0246 or JNJ-5207787.
Analogs were purchased in powder form or re-ordered from the MLSMR in liquid
form and tested in dose response assays against both receptors. Results for
these analogs are summarized in the SAR table below.</p><p><b>Scaffold 3:</b> Based on the above criteria, a compound belonging to
the aryl-1,2,4-oxadiazole scaffold was identified: <b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-4242079</a></b>.
This compound does not share structural similarities with the known NPY-Y2
antagonist BIIE0246 or JNJ-5207787. Analogs were purchased in powder form or
re-ordered from the MLSMR in liquid form and tested in dose response assays
against both receptors. Results for these analogs are summarized in the SAR
table below.</p><p><b>Scaffold 4:</b> Based on the above criteria, a compound belonging to
the dimethylisoxazole scaffold was identified: <b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-22413249</a></b>.
This compound does not share structural similarities with the known NPY-Y2
antagonist BIIE0246 or JNJ-5207787. Analogs were purchased in powder form or
re-ordered from the MLSMR in liquid form and tested in dose response assays
against both receptors. Results for these analogs are summarized in the SAR
table below.</p></div></div><div id="ml075.s10"><h2 id="_ml075_s10_">3. Probe</h2><div id="ml075.s11"><h3>a. Chemical name</h3><p><b>Scaffold 1:</b>
N-(4-ethoxyphenyl)-4-[hydroxy(diphenyl)methyl]piperidine-1-
carbothioamide [<a href="/pcsubstance/?term=ML075[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML075</a>]</p><p><b>Scaffold 2:</b>
4-chloro-3-[(2,5-dimethylphenyl)sulfamoyl]-N-(2-phenylphenyl)benzamide
[<a href="/pcsubstance/?term=ML074[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML074</a>]</p><p><b>Scaffold 3:</b>
2-(2-methoxyphenyl)-N-[4-[5-(3-methoxyphenyl)-1,2,
4-oxadiazol-3-yl]phenyl]acetamide
[<a href="/pcsubstance/?term=ML073[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML073</a>]</p><p><b>Scaffold 4:</b>
3,5-dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]-1,2-oxazole
[<a href="/pcsubstance/?term=ML072[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML072</a>]</p></div><div id="ml075.s12"><h3>b. Probe chemical structure</h3><div id="ml075.fu6" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu1.jpg" alt="Scaffold 1 (Piperidine carbothioamide) [ML075]." /></div><h3><span class="title">Scaffold 1 (Piperidine carbothioamide) [ML075]</span></h3></div><div id="ml075.fu7" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu2.jpg" alt="Scaffold 2 (Arysulfamoyl benzamide) [ML074]." /></div><h3><span class="title">Scaffold 2 (Arysulfamoyl benzamide) [ML074]</span></h3></div><div id="ml075.fu8" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu3.jpg" alt="Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]." /></div><h3><span class="title">Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]</span></h3></div><div id="ml075.fu9" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47354/bin/ml075fu4.jpg" alt="Scaffold 4 (Dimethylisoxazole) [ML072]." /></div><h3><span class="title">Scaffold 4 (Dimethylisoxazole) [ML072]</span></h3></div></div><div id="ml075.s13"><h3>c. Structural Verification Information of probe SID</h3><p>LCMS</p></div><div id="ml075.s14"><h3>d. PubChem CID (corresponding to the SID)</h3><p><b>Scaffold 1:</b> CID-2936384</p><p><b>Scaffold 2:</b> CID-2228302</p><p><b>Scaffold 3:</b> CID-3236979</p><p><b>Scaffold 4:</b> CID-4460128</p></div><div id="ml075.s15"><h3>e. Availabilty from vendor</h3><p><b>Scaffold 1:</b> Asinex, catalog number BAS 01915526</p><p><b>Scaffold 2:</b> ChemBridge, catalog number 7955494</p><p><b>Scaffold 3:</b> ChemDiv, catalog number K907-0250</p><p><b>Scaffold 4:</b> Specs, catalog number AM970/41069539</p></div><div id="ml075.s16"><h3>f. Mode of action for biological activity of probe</h3><p><b>Scaffold 1:</b> Using cell-based <sup>125</sup>I-PYY binding assays, the
Assay Provider has determined that <b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17507305</a></b> competes with
agonist for binding to the NPY Y2 receptor. In cells expressing NPY Y2, this
compound exhibited a K<sub>i</sub> value of 1.55 nM (<a class="bibr" href="#ml075.r1" rid="ml075.r1">1</a>). No significant blockade of <sup>125</sup>I-PYY
binding in cells expressing NPY Y1 was detected, even at concentrations up to 50
&#x003bc;M. These results suggest that this probe binds to the NPY Y2
receptor and does not bind to the Y1 receptor subtype.</p><p><b>Scaffold 2:</b> Using cell-based <sup>125</sup>I-PYY binding assays, the
Assay Provider has determined that <b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17413392</a></b> competes with
agonist for binding to the NPY Y2 receptor. In cells expressing NPY Y2, this
compound exhibited a K<sub>i</sub> value of 1.93 nM (<a class="bibr" href="#ml075.r1" rid="ml075.r1">1</a>). No significant blockade of <sup>125</sup>I-PYY
binding in cells expressing NPY Y1 was detected, even at concentrations up to 50
&#x003bc;M. These results suggest that this probe binds to the NPY Y2
receptor and does not bind to the Y1 receptor subtype.</p><p><b>Scaffold 3:</b> Using cell-based <sup>125</sup>I-PYY binding assays, the
Assay Provider has determined that <b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-4242079</a></b> competes with agonist
for binding to the NPY Y2 receptor. In cells expressing NPY Y2, this compound
exhibited a K<sub>i</sub> value of 6.0 nM (<a class="bibr" href="#ml075.r1" rid="ml075.r1">1</a>). No significant blockade of <sup>125</sup>I-PYY binding in cells
expressing NPY Y1 was detected, even at concentrations up to 50 &#x003bc;M.
These results suggest that this probe binds to the NPY Y2 receptor and does not
bind to the Y1 receptor subtype.</p><p><b>Scaffold 4:</b> Using cell-based <sup>125</sup>I-PYY binding assays, the
Assay Provider has determined that <b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-22413249</a></b> competes with
agonist for binding to the NPY Y2 receptor. In cells expressing NPY Y2, this
compound exhibited a K<sub>i</sub> value of 60.3 nM (<a class="bibr" href="#ml075.r1" rid="ml075.r1">1</a>). No significant blockade of <sup>125</sup>I-PYY
binding in cells expressing NPY Y1 was detected, even at concentrations up to 50
&#x003bc;M. These results suggest that this probe binds to the NPY Y2
receptor and does not bind to the Y1 receptor subtype.</p></div><div id="ml075.s17"><h3>g. Detailed synthetic pathway for making probe</h3><p>Not applicable</p></div><div id="ml075.s18"><h3>h. Probe properties</h3><p><b>Scaffold 1:</b> Aqueous solubility, &#x02212;8.47; ADMET BBB, 0.803;
ADMET BBB level, 0; ADMET absorption level, 0; ADMET solubility,
&#x02212;5.463; ADMET solubility level, 2</p><p><b>Scaffold 2:</b> Aqueous solubility, &#x02212;9.18; ADMET BBB, ND;
ADMET BBB level, 4; ADMET absorption level, 2; ADMET solubility,
&#x02212;7.195; ADMET solubility level, 1</p><p><b>Scaffold 3:</b> Aqueous solubility, &#x02212;6.86; ADMET BBB,
&#x02212;.253; ADMET BBB level, 2; ADMET absorption level, 0; ADMET
solubility, &#x02212;4.849; ADMET solubility level, 2</p><p><b>Scaffold 4:</b> Aqueous solubility, &#x02212;6.11; ADMET BBB, .133;
ADMET BBB level, 1; ADMET absorption level, 0; ADMET solubility,
&#x02212;5.237; ADMET solubility level, 2</p></div><div id="ml075.s19"><h3>i. A tabular presentation summarizing known probe properties</h3><p>Please see Tables of <a class="figpopup" href="/books/NBK47354/table/ml075.t4/?report=objectonly" target="object" rid-figpopup="figml075t4" rid-ob="figobml075t4">Probe
Properties</a> and <a class="figpopup" href="/books/NBK47354/table/ml075.t5/?report=objectonly" target="object" rid-figpopup="figml075t5" rid-ob="figobml075t5">Probe Names</a>.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t4"><a href="/books/NBK47354/table/ml075.t4/?report=objectonly" target="object" title="Table 5" class="img_link icnblk_img figpopup" rid-figpopup="figml075t4" rid-ob="figobml075t4"><img class="small-thumb" src="/books/NBK47354/table/ml075.t4/?report=thumb" src-large="/books/NBK47354/table/ml075.t4/?report=previmg" alt="Table 5. Probe Properties." /></a><div class="icnblk_cntnt"><h4 id="ml075.t4"><a href="/books/NBK47354/table/ml075.t4/?report=objectonly" target="object" rid-ob="figobml075t4">Table 5</a></h4><p class="float-caption no_bottom_margin">Probe Properties. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t5"><a href="/books/NBK47354/table/ml075.t5/?report=objectonly" target="object" title="Table 6" class="img_link icnblk_img figpopup" rid-figpopup="figml075t5" rid-ob="figobml075t5"><img class="small-thumb" src="/books/NBK47354/table/ml075.t5/?report=thumb" src-large="/books/NBK47354/table/ml075.t5/?report=previmg" alt="Table 6. Probe Names." /></a><div class="icnblk_cntnt"><h4 id="ml075.t5"><a href="/books/NBK47354/table/ml075.t5/?report=objectonly" target="object" rid-ob="figobml075t5">Table 6</a></h4><p class="float-caption no_bottom_margin">Probe Names. </p></div></div></div></div><div id="ml075.s20"><h2 id="_ml075_s20_">4. Appendices</h2><ol class="lower-alpha"><li class="half_rhythm"><div>
<b>Comparative data on (<a class="bibr" href="#ml075.r1" rid="ml075.r1">1</a>)
probes, (<a class="bibr" href="#ml075.r2" rid="ml075.r2">2</a>) similar compound
structures (establishing SAR) and (<a class="bibr" href="#ml075.r3" rid="ml075.r3">3</a>) prior probes</b>
</div></li><li class="half_rhythm"><div>
<b>Comparative data showing probe specificity for target</b>
</div></li></ol><p>See Tables <a class="figpopup" href="/books/NBK47354/table/ml075.t6/?report=objectonly" target="object" rid-figpopup="figml075t6" rid-ob="figobml075t6">7a</a>-<a class="figpopup" href="/books/NBK47354/table/ml075.t9/?report=objectonly" target="object" rid-figpopup="figml075t9" rid-ob="figobml075t9">d</a></p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t6"><a href="/books/NBK47354/table/ml075.t6/?report=objectonly" target="object" title="Table 7(a)" class="img_link icnblk_img figpopup" rid-figpopup="figml075t6" rid-ob="figobml075t6"><img class="small-thumb" src="/books/NBK47354/table/ml075.t6/?report=thumb" src-large="/books/NBK47354/table/ml075.t6/?report=previmg" alt="Table 7(a). SAR Scaffold 1: Piperidine-carbothioamide." /></a><div class="icnblk_cntnt"><h4 id="ml075.t6"><a href="/books/NBK47354/table/ml075.t6/?report=objectonly" target="object" rid-ob="figobml075t6">Table 7(a)</a></h4><p class="float-caption no_bottom_margin">SAR Scaffold 1: Piperidine-carbothioamide. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t7"><a href="/books/NBK47354/table/ml075.t7/?report=objectonly" target="object" title="Table 7(b)" class="img_link icnblk_img figpopup" rid-figpopup="figml075t7" rid-ob="figobml075t7"><img class="small-thumb" src="/books/NBK47354/table/ml075.t7/?report=thumb" src-large="/books/NBK47354/table/ml075.t7/?report=previmg" alt="Table 7(b). SAR Scaffold 2: Arylsulfamoylbenzamide." /></a><div class="icnblk_cntnt"><h4 id="ml075.t7"><a href="/books/NBK47354/table/ml075.t7/?report=objectonly" target="object" rid-ob="figobml075t7">Table 7(b)</a></h4><p class="float-caption no_bottom_margin">SAR Scaffold 2: Arylsulfamoylbenzamide. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t8"><a href="/books/NBK47354/table/ml075.t8/?report=objectonly" target="object" title="Table 7(c)" class="img_link icnblk_img figpopup" rid-figpopup="figml075t8" rid-ob="figobml075t8"><img class="small-thumb" src="/books/NBK47354/table/ml075.t8/?report=thumb" src-large="/books/NBK47354/table/ml075.t8/?report=previmg" alt="Table 7(c). SAR Scaffold 3: Aryl-1,2,4-oxadiazole." /></a><div class="icnblk_cntnt"><h4 id="ml075.t8"><a href="/books/NBK47354/table/ml075.t8/?report=objectonly" target="object" rid-ob="figobml075t8">Table 7(c)</a></h4><p class="float-caption no_bottom_margin">SAR Scaffold 3: Aryl-1,2,4-oxadiazole. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075t9"><a href="/books/NBK47354/table/ml075.t9/?report=objectonly" target="object" title="Table 7(d)" class="img_link icnblk_img figpopup" rid-figpopup="figml075t9" rid-ob="figobml075t9"><img class="small-thumb" src="/books/NBK47354/table/ml075.t9/?report=thumb" src-large="/books/NBK47354/table/ml075.t9/?report=previmg" alt="Table 7(d). SAR Scaffold 4: Dimethylisoxazole." /></a><div class="icnblk_cntnt"><h4 id="ml075.t9"><a href="/books/NBK47354/table/ml075.t9/?report=objectonly" target="object" rid-ob="figobml075t9">Table 7(d)</a></h4><p class="float-caption no_bottom_margin">SAR Scaffold 4: Dimethylisoxazole. </p></div></div></div><div id="ml075.bib"><h2 id="_ml075_bib_">5. Bibliography</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="ml075.r1">Saldanha SA, Brothers SP, Spicer T, Cameron M, Mercer BA, Chase P, McDonald P, Wahlestedt C, Hodder PS. Selective and Brain Penetrant Neuropeptide Y Y2 Receptor
Antagonists Discovered through Whole-Cell High Throughput
Screening. <span></span> Submitted. [<a href="/pmc/articles/PMC2802430/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2802430</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19837904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19837904</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="ml075.r2">Bonaventure P, Nepomuceno D, Mazur C, Lord B, Rudolph DA, Jablonowski JA, Carruthers NI, Lovenberg TW. Characterization of
N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide
(JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y 2
receptor. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2004 Mar;<span class="ref-vol">308</span>(3:):1130&ndash;7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14617685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14617685</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="ml075.r3">Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. Estimation of aqueous solubility of chemical compounds using
E-state indices. <span><span class="ref-journal">J Chem Inf Comput Sci. </span>2001;<span class="ref-vol">41</span>:1488&ndash;1493.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11749573" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11749573</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>4.</dt><dd><div class="bk_ref" id="ml075.r4">Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate
statistics. <span><span class="ref-journal">J Med Chem. </span>2000;<span class="ref-vol">43</span>:3867&ndash;3877.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11052792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11052792</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>5.</dt><dd><div class="bk_ref" id="ml075.r5">Egan WJ, Lauri G. Prediction of intestinal permeability. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2002;<span class="ref-vol">54</span>:273&ndash;289.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11922948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11922948</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>6.</dt><dd><div class="bk_ref" id="ml075.r6">Cheng A, Merz KM Jr. Prediction of aqueous solubility of a diverse set of
compounds using quantitative structure-property
relationships. <span><span class="ref-journal">J Med Chem. </span>2003;<span class="ref-vol">46</span>:3572&ndash;3580.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12904062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12904062</span></a>]</div></dd></dl></dl></div><div id="ml075.s21"><h2 id="_ml075_s21_">Brain Penetrance Data</h2><p>In order to determine whether the identified Y2R antagonists were brain-penetrant,
selected compounds were injected intraperitoneally into adult mice at 10 mg/kg and
levels in the brain tissue and plasma were measured after thirty minutes. BIIE 0246,
the current NPY Y2 antagonist probe, exhibited poor penetration (only 2%
of plasma levels). All probes demonstrated a higher brain penetrance than BIIE
0246.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml075tu2"><a href="/books/NBK47354/table/ml075.tu2/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml075tu2" rid-ob="figobml075tu2"><img class="small-thumb" src="/books/NBK47354/table/ml075.tu2/?report=thumb" src-large="/books/NBK47354/table/ml075.tu2/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="ml075.tu2"><a href="/books/NBK47354/table/ml075.tu2/?report=objectonly" target="object" rid-ob="figobml075tu2">Table</a></h4></div></div></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK47354_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><p class="contrib-group"><h4>Authors</h4><span itemprop="author">SA Saldanha</span>, <span itemprop="author">SP Brothers</span>, <span itemprop="author">T Spicer</span>, <span itemprop="author">M Cameron</span>, <span itemprop="author">BA Mercer</span>, <span itemprop="author">P Chase</span>, <span itemprop="author">P McDonald</span>, <span itemprop="author">C Wahlestedt</span>, and <span itemprop="author">PS Hodder</span>.</p><h3>Publication History</h3><p class="small">Received: <span itemprop="datePublished">January 13, 2009</span>; Last Update: <span itemprop="dateModified">August 6, 2010</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p>National Center for Biotechnology Information (US), Bethesda (MD)</p><h3>NLM Citation</h3><p>Saldanha SA, Brothers SP, Spicer T, et al. Probe Report for NPY-Y2 Receptor Antagonists. 2009 Jan 13 [Updated 2010 Aug 6]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/mlprobe/ml076/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/mlprobe/ml071/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="fig" id="figobml075fu1"><div id="ml075.fu1" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu1.jpg" alt="Scaffold 1 (Piperidine carbothioamide) [ML075]." /></div><h3><span class="title">Scaffold 1 (Piperidine carbothioamide) [ML075]</span></h3></div></article><article data-type="fig" id="figobml075fu2"><div id="ml075.fu2" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu2.jpg" alt="Scaffold 2 (Arysulfamoyl benzamide) [ML074]." /></div><h3><span class="title">Scaffold 2 (Arysulfamoyl benzamide) [ML074]</span></h3></div></article><article data-type="fig" id="figobml075fu3"><div id="ml075.fu3" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu3.jpg" alt="Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]." /></div><h3><span class="title">Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]</span></h3></div></article><article data-type="fig" id="figobml075fu4"><div id="ml075.fu4" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu4.jpg" alt="Scaffold 4 (Dimethylisoxazole) [ML072]." /></div><h3><span class="title">Scaffold 4 (Dimethylisoxazole) [ML072]</span></h3></div></article><article data-type="table-wrap" id="figobml075tu1"><div id="ml075.tu1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.tu1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.tu1_lrgtbl__"><table><thead><tr><th id="hd_h_ml075.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Scaffold ID</th><th id="hd_h_ml075.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Scaffold Name</th><th id="hd_h_ml075.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID/ML</th><th id="hd_h_ml075.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SID</th><th id="hd_h_ml075.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target (NPY Y2) IC<sub>50</sub>
(&#x003bc;M)</th><th id="hd_h_ml075.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Anti-Target (NPY Y1) IC<sub>50</sub>
(&#x003bc;M)</th><th id="hd_h_ml075.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Secondary Assay CC<sub>50</sub>
(&#x003bc;M)</th><th id="hd_h_ml075.tu1_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Brain Penetrance (ng/mL)</th></tr></thead><tbody><tr><td headers="hd_h_ml075.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1</td><td headers="hd_h_ml075.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Piperidine carbothioamide</td><td headers="hd_h_ml075.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2936384/<a href="/pcsubstance/?term=ML075[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML075</a></td><td headers="hd_h_ml075.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">17507305</a></td><td headers="hd_h_ml075.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.220
[<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1272</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35
[<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1279</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">74</td><td headers="hd_h_ml075.tu1_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1656 &#x000b1; 749</td></tr><tr><td headers="hd_h_ml075.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2</td><td headers="hd_h_ml075.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Arysulfamoylbenzamide</td><td headers="hd_h_ml075.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2228302/<a href="/pcsubstance/?term=ML074[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML074</a></td><td headers="hd_h_ml075.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">17413392</a></td><td headers="hd_h_ml075.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.428
[<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1272</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4
[<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1279</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20.6</td><td headers="hd_h_ml075.tu1_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">395 &#x000b1; 16</td></tr><tr><td headers="hd_h_ml075.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3</td><td headers="hd_h_ml075.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Aryl-1,2,4-oxadiazole</td><td headers="hd_h_ml075.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3236979/<a href="/pcsubstance/?term=ML073[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML073</a></td><td headers="hd_h_ml075.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">4242079</a></td><td headers="hd_h_ml075.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.733 [<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1272</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35 [<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1279</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.tu1_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1860 &#x000b1; 135</td></tr><tr><td headers="hd_h_ml075.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4</td><td headers="hd_h_ml075.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Dimethylisoxazole</td><td headers="hd_h_ml075.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4460128/<a href="/pcsubstance/?term=ML072[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML072</a></td><td headers="hd_h_ml075.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">22413249</a></td><td headers="hd_h_ml075.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.917 [<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1272</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4 [<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1279</a>]</td><td headers="hd_h_ml075.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.tu1_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">513 &#x000b1; 57</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t1"><div id="ml075.t1" class="table"><h3><span class="label">Table 2</span><span class="title">PubChem BioAssay</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t1_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AID</th><th id="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Assay Name</th><th id="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Assay Type</th><th id="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target</th><th id="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Powder Sample</th><th id="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Compound Concentration</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">793</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primary cell based
high-throughput screening assay for antagonists of
neuropeptide Y receptor Y2.</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Primary Assay (1X
%INH)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y2</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.7&#x003bc;M</td></tr><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1256" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1256</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Counterscreen assay for
antagonists of neuropeptide Y receptor Y2 (NPY-Y2):
Cell-based high throughput assay to measure NPY-Y1
antagonism.</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Counterscreen Assay (3X
%INH)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y1</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.6 &#x003bc;M</td></tr><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1257" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1257</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cell-based high throughput
confirmation assay for antagonists of neuropeptide Y
receptor.</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Confirmation Assay (3X
%INH)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y2</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.7 &#x003bc;M</td></tr><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1272</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dose response cell-based
screening assay for antagonists of neuropeptide Y receptor
Y2.</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Dose Response (3X
IC<sub>50</sub>)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y2</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">10-point, 1:3 dilution
starting at 35 &#x003bc;M</td></tr><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1040" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1040</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primary cell-based
high-throughput screening assay for antagonists of
NPY-Y1</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Primary Assay (1X
%INH)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y1</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.6 &#x003bc;M</td></tr><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1279</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dose response counterscreen for
neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high
throughput assay to measure NPY-Y1 antagonism.</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Dose Response Counterscreen
(3X IC<sub>50</sub>)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y1</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">10-point, 1:3 dilution
starting at 35 &#x003bc;M</td></tr><tr><td headers="hd_h_ml075.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/2142" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">2142</a></td><td headers="hd_h_ml075.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late stage results from the
probe development effort to identify antagonists of
neuropeptide Y receptor Y2 (NPY-Y2)</td><td headers="hd_h_ml075.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Various (Cytotoxicity and
Brain Penetrance assays)</td><td headers="hd_h_ml075.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">NPY-Y2</td><td headers="hd_h_ml075.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Yes</td><td headers="hd_h_ml075.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Various</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t2"><div id="ml075.t2" class="table"><h3><span class="label">Table 3</span><span class="title">Assay Rationale and Description</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t2_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">AID</th><th id="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Assay Rationale</th><th id="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Assay Description</th><th id="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Z&#x02032;</th><th id="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">S:B</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">793</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine the ability of test compounds to inhibit NPY Y2
activity.</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">In this assay test compounds are
screened for their ability to increase agonist-mediated cAMP
levels in a cell line transfected with the NPY-Y2 receptor
and a cyclic-nucleotide gated channel (CNG). The cells are
treated with isoproterenol to activate adenylate cyclase and
open the CNG channel, leading to a change in membrane
potential that is measured using a fluorescent probe. The
addition of the agonist NPY peptide counteracts cAMP
accumulation induced by isoproterenol. As designed, test
compounds that act as NPY-Y2 receptor antagonists will
reverse the reduction in well fluorescence.</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.78+/&#x02212; 0.04</td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">5.09
+/&#x02212; 0.33</td></tr><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1256" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1256</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine the ability of test compounds to inhibit NPY Y1
activity.</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-793</a>, except that
test compounds are tested in triplicate and are incubated
with a cell line that is transfected with the NPY-Y1
receptor.</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.79
+/&#x02212; 0.01</td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4.28
+/&#x02212; 0.04</td></tr><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1257" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1257</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
confirm activity of compounds previously identified as
active in a previous set of experiments (PubChem AID
793).</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-793</a>, except that
compounds are tested in triplicate..</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.81+/&#x02212; 0.02</td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.99
+/&#x02212; 0.13</td></tr><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1272</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine dose response curves for compounds identified as
active in a previous set of experiments entitled, "Primary
cell-based high-throughput screening assay for antagonists
of neuropeptide Y receptor Y2 (NPY-Y2)," (PubChem AID
793).</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-793</a>, except that
test compounds were assayed in triplicate in a 10-point, 1:3
dilution series starting at a nominal test concentration of
35 &#x003bc;M.</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.84
+/&#x02212; 0.02</td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4.04
+/&#x02212; 0.19</td></tr><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1040" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1040</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine the ability of test compounds to inhibit NPY Y1
activity.</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1256" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1256</a>, except that
test compounds are incubated with a cell line that is
transfected with the NPY-Y1 receptor.</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.65+/&#x02212; 0.06</td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.35
+/&#x02212; 0.28</td></tr><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1279</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine whether compounds identified as active in a
previous set of experiments (PubChem <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-793</a>) were
nonselective due to inhibition of the NPY Y1 receptor.</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">AID-1272</a>, except that
test compounds are incubated with a cell line that is
transfected with the NPY-Y1 receptor.</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.70+/&#x02212; 0.10</td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.56+/&#x02212;0.09</td></tr><tr><td headers="hd_h_ml075.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/2142" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">2142</a></td><td headers="hd_h_ml075.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine whether probe candidates were cytotoxic and brain
penetrant.</td><td headers="hd_h_ml075.t2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The purpose of this assay is to
determine whether compounds of interest reduce cell
viability. Y2R HEK293-CNG cells were seeded at 500 cells per
well in 1536-well plates in 5 uL growth media. Compounds (in
DMSO) were prepared as 10-point, 1:3 serial dilutions
starting at 11 &#x000b5;M final concentration were added to cells.
Plates were incubated for 24, 48 or 72 h at 37 C. After
incubation, 5 uL of CellTiter-Glo (Promega, Madison, WI)
were added to each well and the plates were allowed to
incubate for 15 min at room temperature. Luminescence was
then measured (ViewLux plate reader, PerkinElmer, Turku,
Finland). Viability was measured as a percentage relative to
control cells treated with DMSO alone (0%
cytotoxicity) and cells treated with 100 &#x000b5;M Doxorubicin
(100% cytotoxicity).<br /><br />Plasma and
brain levels of the compounds were assessed in C57Bl6 mice
30 minutes after dosing 10 mg/kg intraperitoneally. Samples
were formulated at 2 mg/mL in 10/10/80 DMSO/tween/water.
Blood was collected into EDTA containing tubes at 30 min and
plasma was generated using standard centrifugation
techniques. Brain samples were frozen upon collection and
all samples were stored at &#x02212;80 C until analyzed.
Brain tissue was not perfused prior to freezing to prevent
diffusion of the compound out of the tissue during the
process. Plasma samples were analyzed by treating 25
&#x003bc;L of plasma with 125 &#x003bc;L of
acetonitrile containing an internal standard (propanolol)
and filtering through a Millipore Multiscreen Solvinter 0.45
&#x003bc;m low binding PTFE hydrophilic filter. The
filtrate was analyzed by LC- MS/MS using an API Sciex 4000.
MRM methods were developed in positive ion mode and
concentrations were determined using a standard curve
between 2 to 2000 ng/mL. Samples with concentrations outside
of the curve were diluted with blank plasma and reanalyzed.
Similar conditions were used to determine brain levels
except the samples were weighed and acetonitrile was added
(10x, weight by volume). The samples were sonicated to
extract the compound from the brain matrix and then filtered
as described above. A density of 1 g/mL was used to convert
compound per mg tissue into molar equivalents.</td><td headers="hd_h_ml075.t2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"></td><td headers="hd_h_ml075.t2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"></td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t3"><div id="ml075.t3" class="table"><h3><span class="label">Table 4</span><span class="title">Reagents and Source</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t3_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t3_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AID</th><th id="hd_h_ml075.t3_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Reagent (Source)</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t3_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/793" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">793</a>, <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1256" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1256</a>, <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1257" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1257</a>, and <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1272</a></b>
</td><td headers="hd_h_ml075.t3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropeptide Y receptor Y2
HEK293-CNG cells (BD Biosciences, part 344870)<br /> 10x
ACTOne Membrane Potential Assay Kit (BD Biosciences, part
<a href="/nuccore/92255785" class="bk_tag" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=nuccore">BD354663</a>)<br /> Phosphate Buffered Saline (Invitrogen,
part 10010-023)<br /> DMEM (Invitrogen, part
11965-092)<br /> Fetal Bovine Serum (Invitrogen, part
16140-071)<br /> Trypsin-EDTA solution (Invitrogen, part
25200-056)<br /> Geneticin (Invitrogen, part
10131-027)<br /> Puromycin (Sigma, part P9620)<br />
Isoproterenol (Sigma, part I6504)<br /> Ro 20-1724 (Sigma,
part B8279)<br /> Neuropeptide Y (American Peptide, part
60-1-11B)<br /> BIIE 0246 (Tocris, part 1700)<br />
1536-well plates (Greiner, part 789072)<br /> T-175 tissue
culture flasks (Corning, part 431)</td></tr><tr><td headers="hd_h_ml075.t3_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1040" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1040</a> and <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">1279</a></b>
</td><td headers="hd_h_ml075.t3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As above, with the
following changes: Neuropeptide Y receptor
Y1 HEK293-CNG cells (BD Biosciences, part 344869) (replaces
Y2 cells)</td></tr><tr><td headers="hd_h_ml075.t3_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/2142" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">2142</a></td><td headers="hd_h_ml075.t3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Y2R HEK293-CNG cells ;
CellTiter-Glo (Promega, Madison, WI); DMSO; Doxorubicin
DMSO/tween/water; EDTA; acetonitrile containing an internal
standard (propanolol)</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml075fu6"><div id="ml075.fu6" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu1.jpg" alt="Scaffold 1 (Piperidine carbothioamide) [ML075]." /></div><h3><span class="title">Scaffold 1 (Piperidine carbothioamide) [ML075]</span></h3></div></article><article data-type="fig" id="figobml075fu7"><div id="ml075.fu7" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu2.jpg" alt="Scaffold 2 (Arysulfamoyl benzamide) [ML074]." /></div><h3><span class="title">Scaffold 2 (Arysulfamoyl benzamide) [ML074]</span></h3></div></article><article data-type="fig" id="figobml075fu8"><div id="ml075.fu8" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu3.jpg" alt="Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]." /></div><h3><span class="title">Scaffold 3 (Aryl-1,2,4-oxadiazole) [ML073]</span></h3></div></article><article data-type="fig" id="figobml075fu9"><div id="ml075.fu9" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47354/bin/ml075fu4.jpg" alt="Scaffold 4 (Dimethylisoxazole) [ML072]." /></div><h3><span class="title">Scaffold 4 (Dimethylisoxazole) [ML072]</span></h3></div></article><article data-type="table-wrap" id="figobml075t4"><div id="ml075.t4" class="table"><h3><span class="label">Table 5</span><span class="title">Probe Properties</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t4_lrgtbl__"><table class="no_margin"><thead><tr><th id="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scaffold:</th><th id="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1</th><th id="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2</th><th id="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3</th><th id="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>CID</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2936384</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2228302</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3236979</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4460128</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>SID</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">17507305</a></td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">17413392</a></td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">4242079</a></td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">22413249</a></td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>ML#</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="/pcsubstance/?term=ML075[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML075</a></td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="/pcsubstance/?term=ML074[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML074</a></td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="/pcsubstance/?term=ML073[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML073</a></td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="/pcsubstance/?term=ML072[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML072</a></td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>MLS</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">MLS000569101</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">MLS000581978</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">MLS000047258</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">MLS000698406</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>MF</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">C<sub>27</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>S</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">C<sub>27</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>3</sub>S</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">C<sub>24</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub></td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">C<sub>19</sub>H<sub>19</sub>NO<sub>3</sub>S</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>MW</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">446.6043</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">491.00112</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">415.4412</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">341.4240</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Formal Charge</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>H Acceptor</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">6</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>H Donor</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Atom Count</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">32</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">34</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">31</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">24</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Rotatable Bonds</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">6</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">6</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">7</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Rings</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Stereoatoms</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>AlogP</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">6.443</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">6.257</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3.931</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3.92</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>logD</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">5.99</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">6.257</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3.931</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3.92</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Topological Polar Surface Area</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">44.7</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">75.3</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">86.48</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">60.2</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Aqueous solubility</b>
<sup>a</sup>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;8.47</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;9.18</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;6.86</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;6.11</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>ADMET BBB</b>
<sup>b</sup>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.803</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">ND</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;.253</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">.133</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>ADMET BBB level</b>
<sup>c</sup>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>ADMET absorption level</b>
<sup>d</sup>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>ADMET solubility</b>
<sup>e</sup>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;5.463</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;7.195</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;4.849</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">&#x02212;5.237</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>ADMETT solubility level</b>
<sup>f</sup>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Vendor</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Asinex</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">ChemBridge</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">ChemDiv</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Specs</td></tr><tr><td headers="hd_h_ml075.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<b>Vendor Catalog Number</b>
</td><td headers="hd_h_ml075.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">BAS 01915526</td><td headers="hd_h_ml075.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">7955494</td><td headers="hd_h_ml075.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">K907-0250</td><td headers="hd_h_ml075.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">AM970/41069539</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt>a</dt><dd><div id="ml075.tfn1"><p class="no_margin">Aqueous solubility is expressed as logS, where S is solubility in
mol/L. The method used is the multiple linear regression model based
on Electrotopological State indices published in (<a class="bibr" href="#ml075.r2" rid="ml075.r2">2</a>).</p></div></dd></dl><dl class="bkr_refwrap"><dt>b</dt><dd><div id="ml075.tfn2"><p class="no_margin">ADMET_BBB: Log of Brain/Blood partition coefficient (LogBB). See
(<a class="bibr" href="#ml075.r4" rid="ml075.r4">4</a>) for details on
this method.</p></div></dd></dl><dl class="bkr_refwrap"><dt>c</dt><dd><div id="ml075.tfn3"><p class="no_margin">ADMET_BBB_Level: Ranking of the LogBB values into one of the
following levels (see (<a class="bibr" href="#ml075.r4" rid="ml075.r4">4</a>, <a class="bibr" href="#ml075.r5" rid="ml075.r5">5</a>) for
details): 0: Very High 1: High 2: Medium 3: Low 4: Undefined
(molecule is outside the confidence area of the regression
model).</p></div></dd></dl><dl class="bkr_refwrap"><dt>d</dt><dd><div id="ml075.tfn4"><p class="no_margin">ADMET Passive Intestinal Absorption properties. A ranking of the
molecule into one of the following levels (see (<a class="bibr" href="#ml075.r4" rid="ml075.r4">4</a>, <a class="bibr" href="#ml075.r5" rid="ml075.r5">5</a>) for details): 0: Good 1: Moderate 2: Poor 3: Very
Poor</p></div></dd></dl><dl class="bkr_refwrap"><dt>e</dt><dd><div id="ml075.tfn5"><p class="no_margin">ADMET_Solubility: Log of the water solubility at 25 degrees, LogSw,
in mol/L. See (<a class="bibr" href="#ml075.r6" rid="ml075.r6">6</a>) for
more information.</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobml075t5"><div id="ml075.t5" class="table"><h3><span class="label">Table 6</span><span class="title">Probe Names</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t5_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Scaffold</th><th id="hd_h_ml075.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Probe CID</th><th id="hd_h_ml075.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Probe SID</th><th id="hd_h_ml075.t5_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Probe Name (IUPAC)</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<b>1</b>
</td><td headers="hd_h_ml075.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2936384</td><td headers="hd_h_ml075.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">17507305</a></td><td headers="hd_h_ml075.t5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N-(4-ethoxyphenyl)-4-[hydroxy-di(phenyl)methyl]piperidine-1-carbothioamide
[<a href="/pcsubstance/?term=ML075[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML075</a>]</td></tr><tr><td headers="hd_h_ml075.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<b>2</b>
</td><td headers="hd_h_ml075.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2228302</td><td headers="hd_h_ml075.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">17413392</a></td><td headers="hd_h_ml075.t5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4-chloro-3-[(2,5-dimethylphenyl)sulfamoyl]-N-(2-phenyl
phenyl) benzamide [<a href="/pcsubstance/?term=ML074[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML074</a>]</td></tr><tr><td headers="hd_h_ml075.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<b>3</b>
</td><td headers="hd_h_ml075.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3236979</td><td headers="hd_h_ml075.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">4242079</a></td><td headers="hd_h_ml075.t5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-(2-methoxyphenyl)-N-[4-[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-
yl]phenyl]acetamide[<a href="/pcsubstance/?term=ML073[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML073</a>]</td></tr><tr><td headers="hd_h_ml075.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<b>4</b>
</td><td headers="hd_h_ml075.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4460128</td><td headers="hd_h_ml075.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">22413249</a></td><td headers="hd_h_ml075.t5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3,5-dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]-1,2-oxazole
[<a href="/pcsubstance/?term=ML072[synonym]" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=pubchem">ML072</a>]</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t6"><div id="ml075.t6" class="table"><h3><span class="label">Table 7(a)</span><span class="title">SAR Scaffold 1: Piperidine-carbothioamide</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t6/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t6_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t6_1_1_1_1" colspan="10" rowspan="1" style="text-align:left;vertical-align:top;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu10.jpg" alt="Image ml075fu10.jpg" /></div>
</th></tr><tr><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SID</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Vendor</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Catalog ID</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target: NPY-Y2 IC<sub>50</sub>
(&#x003bc;M)</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Anti- Target: NPY-Y1 IC<sub>50</sub>
(&#x003bc;M)</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CC<sub>50</sub> (&#x003bc;M)</th><th headers="hd_h_ml075.t6_1_1_1_1" id="hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Brain Penetrance</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu11.jpg" alt="Image ml075fu11.jpg" /></div>
</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17507305</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2936384</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000569101</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Asinex</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">BAS 01915526</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.20E-07</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">74</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1656 &#x000b1; 749 ng/mL</td></tr><tr><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu12.jpg" alt="Image ml075fu12.jpg" /></div>
</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17431723</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2936750</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000552281</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Asinex</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">BAS 01915519</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1.59E-06</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu13.jpg" alt="Image ml075fu13.jpg" /></div>
</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">56365809</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1261254</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-002454455</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7357839</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1.83E-06</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;59.6</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu14.jpg" alt="Image ml075fu14.jpg" /></div>
</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17433143</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2945630</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000579559</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7653223</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1.26E-05</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu15.jpg" alt="Image ml075fu15.jpg" /></div>
</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17505667</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3649536</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000331483</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">InterBio Screen</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">STOCK4S-45177</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1.42E-05</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu16.jpg" alt="Image ml075fu16.jpg" /></div>
</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">56365810</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1934050</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-002454456</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7353950</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">60.1</td><td headers="hd_h_ml075.t6_1_1_1_1 hd_h_ml075.t6_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t7"><div id="ml075.t7" class="table"><h3><span class="label">Table 7(b)</span><span class="title">SAR Scaffold 2: Arylsulfamoylbenzamide</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t7/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t7_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t7_1_1_1_1" colspan="12" rowspan="1" style="text-align:left;vertical-align:top;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu17.jpg" alt="Image ml075fu17.jpg" /></div>
</th></tr><tr><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R1</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R2</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R3</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SID</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Vendor</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Catalog ID</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target: NPY-Y2 IC<sub>50</sub>
(&#x003bc;M) or % Inhibition</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Anti- Target: NPY-Y1 IC<sub>50</sub>
(&#x003bc;M) or % Inhibition</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CC<sub>50</sub> (&#x003bc;M)</th><th headers="hd_h_ml075.t7_1_1_1_1" id="hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Brain Penetrance</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu18.jpg" alt="Image ml075fu18.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17413392</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2228302</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000581978</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7955494</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4.28E-07</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20.6</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">395 &#x000b1; 16 ng/mL</td></tr><tr><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CH<sub>3</sub></td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu19.jpg" alt="Image ml075fu19.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17413034</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2223246</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000582311</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7930722</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.98E-07</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">67</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">805 &#x000b1; 305 ng/mL</td></tr><tr><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CH<sub>3</sub></td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu20.jpg" alt="Image ml075fu20.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">56365811</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2242162</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-002454457</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7989629</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.18E-06</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">36.7</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td></tr><tr><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu21.jpg" alt="Image ml075fu21.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17412946</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2233210</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000582690</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7969716</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.58E-06</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35.4</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">77.3</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td></tr><tr><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CH<sub>3</sub></td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu22.jpg" alt="Image ml075fu22.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17413562</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2229952</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000582081</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7962686</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">15.4% @ 2.8
&#x003bc;M</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.7% @ 3.5
&#x003bc;M</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td></tr><tr><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu23.jpg" alt="Image ml075fu23.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cl</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu24.jpg" alt="Image ml075fu24.jpg" /></div>
</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17413799</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2228493</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000581991</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7956409</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.6% @ 2.8
&#x003bc;M</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">8.5% @ 3.5
&#x003bc;M</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td><td headers="hd_h_ml075.t7_1_1_1_1 hd_h_ml075.t7_1_1_2_12" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t8"><div id="ml075.t8" class="table"><h3><span class="label">Table 7(c)</span><span class="title">SAR Scaffold 3: Aryl-1,2,4-oxadiazole</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t8/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t8_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t8_1_1_1_1" colspan="11" rowspan="1" style="text-align:left;vertical-align:top;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu25.jpg" alt="Image ml075fu25.jpg" /></div>
</th></tr><tr><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R1</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R2</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SID</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Vendor</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Catalog ID</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target: NPY-Y2 IC<sub>50</sub>
(&#x003bc;M)</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Anti- Target: NPY-Y1 IC<sub>50</sub>
(&#x003bc;M)</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CC<sub>50</sub> (&#x003bc;M)</th><th headers="hd_h_ml075.t8_1_1_1_1" id="hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Brain Penetrance</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu26.jpg" alt="Image ml075fu26.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu27.jpg" alt="Image ml075fu27.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4242079</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3236979</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000047258</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemDiv</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">K907-0250</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.733</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1860 &#x000b1; 135 ng/mL</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu28.jpg" alt="Image ml075fu28.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu29.jpg" alt="Image ml075fu29.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4255014</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2202984</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000049615</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7770357</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4.24</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu30.jpg" alt="Image ml075fu30.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu31.jpg" alt="Image ml075fu31.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">14736723</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2201684</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000536402</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7759153</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4.07</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">26</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu32.jpg" alt="Image ml075fu32.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu33.jpg" alt="Image ml075fu33.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4241999</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3236909</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000047247</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemDiv</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">K907-0086</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4.63</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;11.8</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu34.jpg" alt="Image ml075fu34.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu35.jpg" alt="Image ml075fu35.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">56365812</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1291267</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">None</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7748574</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">13.8</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">81</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu36.jpg" alt="Image ml075fu36.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu37.jpg" alt="Image ml075fu37.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">56365813</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1292769</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">None</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7757524</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">34.4</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">30.5</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu38.jpg" alt="Image ml075fu38.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu39.jpg" alt="Image ml075fu39.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4246387</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3240741</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000047246</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemDiv</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">K907-0083</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">39</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu40.jpg" alt="Image ml075fu40.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu41.jpg" alt="Image ml075fu41.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4244380</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3238986</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000047248</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemDiv</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">K907-0094</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">68.6</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu42.jpg" alt="Image ml075fu42.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu43.jpg" alt="Image ml075fu43.jpg" /></div>
</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">14731189</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3425642</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000521294</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemDiv</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">K907-0080</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">23.7</td><td headers="hd_h_ml075.t8_1_1_1_1 hd_h_ml075.t8_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075t9"><div id="ml075.t9" class="table"><h3><span class="label">Table 7(d)</span><span class="title">SAR Scaffold 4: Dimethylisoxazole</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.t9/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.t9_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml075.t9_1_1_1_1" colspan="11" rowspan="1" style="text-align:left;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu44.jpg" alt="Image ml075fu44.jpg" /></div>
</th></tr><tr><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R1</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">R2</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SID</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Vendor</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Catalog ID</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target: NPY-Y2 IC<sub>50</sub>
(&#x003bc;M) or % Inhibition</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Anti- Target: NPY-Y1 IC<sub>50</sub>
(&#x003bc;M) or % Inhibition</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CC<sub>50</sub> (&#x003bc;M)</th><th headers="hd_h_ml075.t9_1_1_1_1" id="hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Brain Penetrance</th></tr></thead><tbody><tr><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu45.jpg" alt="Image ml075fu45.jpg" /></div>
</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">22413249</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4460128</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000698406</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Specs</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AM-970/41069539</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.92</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">513 &#x000b1; 57 ng/mL</td></tr><tr><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu46.jpg" alt="Image ml075fu46.jpg" /></div>
</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">22413387</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3402760</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000698150</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Specs</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AM-970/41069493</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">8.19</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;99</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">H</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu47.jpg" alt="Image ml075fu47.jpg" /></div>
</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17386121</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4685085</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000538224</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Specs</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AM-970/41069552</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.4% @ 2.8
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0.7% @ 3.5
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">H</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu48.jpg" alt="Image ml075fu48.jpg" /></div>
</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17410523</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1471864</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000326274</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Ambinter</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11L-541S</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.3% @ 2.8
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">10.8% @ 3.5
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">H</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">
<div class="graphic"><img src="/books/NBK47354/bin/ml075fu49.jpg" alt="Image ml075fu49.jpg" /></div>
</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17410952</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1486788</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000326284</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Ambinter</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">8L-520S</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">5.7% @ 2.8
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">18.1% @ 3.5
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr><tr><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Phenyl</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">17386328</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">4386086</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-000324960</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Chem Spider</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3587851</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2.5% @ 2.8
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_9" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1.8% @ 3.5
&#x003bc;M</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_10" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not Tested</td><td headers="hd_h_ml075.t9_1_1_1_1 hd_h_ml075.t9_1_1_2_11" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Not tested</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml075tu2"><div id="ml075.tu2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47354/table/ml075.tu2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml075.tu2_lrgtbl__"><table><thead><tr><th id="hd_h_ml075.tu2_1_1_1_1" rowspan="2" colspan="1" headers="hd_h_ml075.tu2_1_1_1_1" style="text-align:center;vertical-align:middle;">ID</th><th id="hd_h_ml075.tu2_1_1_1_2" colspan="3" rowspan="1" style="text-align:center;vertical-align:middle;">Brain Penetration
Studies<span class="hr"></span></th></tr><tr><th headers="hd_h_ml075.tu2_1_1_1_2" id="hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Plasma Concentration
(&#x003bc;M)</th><th headers="hd_h_ml075.tu2_1_1_1_2" id="hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Brain Concentration
(&#x003bc;M)</th><th headers="hd_h_ml075.tu2_1_1_1_2" id="hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Ratio
[B]/[P]
(%)</th></tr></thead><tbody><tr><td headers="hd_h_ml075.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17507305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17507305</a></b>
</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">8.5 &#x000b1; 3.3</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3.7 &#x000b1; 1.7</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">44</td></tr><tr><td headers="hd_h_ml075.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413392" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17413392</a></b>
</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.1 &#x000b1; 0.1</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.4 &#x000b1; 0.03</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">36</td></tr><tr><td headers="hd_h_ml075.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/17413034" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-17413034</a></b>
</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.6 &#x000b1; 0.6</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.7 &#x000b1; 0.6</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">106</td></tr><tr><td headers="hd_h_ml075.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/4242079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-4242079</a></b>
</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">9.0 &#x000b1; 0.7</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4.5 &#x000b1; 0.3</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">50</td></tr><tr><td headers="hd_h_ml075.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
<b><a href="https://pubchem.ncbi.nlm.nih.gov/substance/22413249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">SID-22413249</a></b>
</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.3 &#x000b1; 0.3</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.5 &#x000b1; 0.2</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">115</td></tr><tr><td headers="hd_h_ml075.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
<b>BIIE-0246</b>
</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">12 &#x000b1; 2</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.2 &#x000b1; 0.1</td><td headers="hd_h_ml075.tu2_1_1_1_2 hd_h_ml075.tu2_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td></tr></tbody></table></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
<!-- Book content -->
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
</html>